Table 1

Characteristics of the study population according to case and control status

CharacteristicsCRC cases, n (%)Controls, n (%)P value8
Total4,8443,964
Age (years), median (Q1, Q3)69 (61, 76)69 (62, 76)
Gender
 Female1,897 (39.2)1,517 (38.3)
 Male2,947 (60.8)2,447 (61.7)
School education (years)1<0.0001
 < 93,172 (65.5)2,185 (55.5)
 9–10855 (17.7)837 (21.1)
 > 10808 (16.7)936 (23.6)
Smoking<0.0001
 Current or former (≥ 30 pack years)1,081 (22.3)706 (17.8)
 Never or former (< 30 pack years)3,763 (77.7)3,258 (82.2)
Alcohol consumption (g/d), mean (SE)2
 Women5.1 (0.2)5.7 (0.2)<0.0001
 Men22.4 (0.4)19.2 (0.4)<0.0001
Diet quality score, mean (SE)30.5 (0.1)32.1 (0.1)<0.0001
Physical activity (MET-hours/week), mean (SE)340.3 (0.6)45.8 (0.7)<0.0001
BMI (kg/m2)4<0.0001
 Overweight or obese (≥ 25)3,403 (70.3)2,460 (62.1)
 Healthy weight (18.5 to < 25)1,441 (29.7)1,504 (37.9)
Healthy lifestyle score<0.0001
 054 (1.1)18 (0.5)
 1345 (7.1)174 (4.4)
 21,130 (23.3)686 (17.3)
 31,726 (35.6)1,347 (34.0)
 41,237 (25.5)1,182 (29.8)
 5352 (7.3)557 (14.1)
Family history of CRC5710 (14.7)431 (10.9)<0.0001
History of colonoscopy1,282 (26.5)2,386 (60.2)<0.0001
Participation in routine health check-ups64,123 (85.1)3,646 (92.0)<0.0001
Regular use of NSAIDs1,394 (28.8)1,509 (38.1)<0.0001
Cancer sites
 Colon cancer2,950 (60.9)/
 Rectum cancer1,894 (39.1)/
Cancer stages7
 I1,110 (22.9)/
 II1,476 (30.5)/
 III1,529 (31.6)/
 IV686 (14.2)/

1Data are missing for 15 participants. 2Lifetime average alcohol consumption, calculated on the basis of self-recalled alcohol consumption at the ages of 20, 30, 40, 50, 60, 70, and 80 years. 3Non-occupational physical activity from the most recent decade preceding the date of diagnosis/interview. 4BMI at approximately 10 years before diagnosis/interview. 5Data are missing for 6 participants. 6Data are missing for 32 participants. 7Data are missing for 43 cases. 8P values are not reported for the matching factors. BMI, body mass index; CRC, colorectal cancer; MET, metabolic equivalent task; NSAID, non-steroidal anti-inflammatory drug; Q, quartile; SE, standard error.